leadership
confidence high
sentiment negative
materiality 0.65
Qualigen Therapeutics reduces executive salaries by 20%, terminates COO Shishir Sinha and CSO Wajdi Abdul-Ahad
AIxCrypto Holdings, Inc.
- Board approved 20% temporary base salary reduction for all executive officers, including CEO, CFO, President, COO, and CMO, effective immediately.
- COO Shishir Sinha terminated effective Feb 16, 2023; President Amy Broidrick's title becomes President, Chief Strategy and Operating Officer.
- Non-executive director annual cash compensation reduced by 20%.
- VP and Chief Scientific Officer Wajdi Abdul-Ahad position eliminated, along with several other non-executive roles.